Innovation and Patents Sectore Report - December 2016

11DECEMBER 2016
INNOVATION AND PATENTS
For updated information, please visit www.ibef.orgDECEMBER 2016

22DECEMBER 2016 For updated information, please visit www.ibef.org
 Executive Summary………….…….………….3
 Advantage India…………………….…………4
 Market Overview and Trends……….………..6
 Porter’s Five Forces Analysis …………...…27
 Strategies Adopted…………………….…….30
 Growth Drivers………………………………..33
 Opportunities………………………………….41
 Success Stories………………………………45
 Useful Information……………………..…….51
DECEMBER 2016

EXECUTIVE SUMMARY
Source: Reserve Bank of India, R&D Magazine, International Monetary Fund, World Bank,
CIA Fact Book, OECD, TechSci Research
Note: R&D - Research and Development;
Figures mentioned are as per latest data available
Sixth-largest R&D
investor
• In 2015, India’s R&D expenditure increased to USD66.49 million from USD61.85 billion in
2014.
• In 2015, India became the world’s sixth largest annual R&D spending country, accounting
for 3.53 per cent of global R&D expenditure
• R&D spending in India is anticipated to grow from 0.9% to 2.4% of the country’s GDP from
2014 to 2034 respectively
• As per the latest World Intellectual Property Organization (WIPO) report published in
September 2015, India’s position moved up from 85th to 61st in the Global Innovation Index
Pharma sector driving
R&D growth
• India’s pharmaceutical industry, which accounts for about 1.4 per cent of the global
pharmaceutical industry in value terms and 10 per cent in volume terms, is expected to
remain a major R&D growth driver
Rapidly growing
overseas investment
• Cumulative overseas direct investments by India grew at a CAGR of 38.78 per cent,
during FY08-16, reaching USD289 billion during FY16 from USD21 billion in FY08, global
car makers are also looking to move their R&D investments in India

ADVANTAGE INDIA

55DECEMBER 2016
Growing demand
For updated information, please visit www.ibef.org
ADVANTAGE INDIA
Source: R&D spending estimate by Battelle and R&D Magazine, TechSci Research
Notes: F - Forecast, E – Estimated, IPR - Intellectual Property Rights, CoE - Center of Excellence, PPP - Public Private Partnership, TRIPS - Trade Related Aspects
of Intellectual Property Rights, NMITLI - New Millennium Indian Technology Leadership Initiative, NIC - National Innovation Council;
Robust demand
• Rising income and evolving
lifestyles have led to higher
demand for aspirational products
• Indian companies’ investments in
R&D is not surprising given the
importance of innovation to
sustain competitive edge
• Indian players are set to benefit
from expiration of patents
Attractive opportunities
• Indian Computer Emergency
Response Team (CERT-In) and
Cisco have signed a MoU for
strategic cybersecurity cooperation,
which aims to enhance digital security
readiness and awareness.
• India is the top exporter of IT products
and has the third largest pharma
sector with a fast growing contract
research segment
Policy support
• PPP for promoting exchange of
scientific knowledge and R&D
• Strengthening educational
infrastructure
• Amendments to the Patents Act
(1970) to make it TRIPS-compliant
• Setting up of NIC in 2010
• Adoption of Science, Technology
and Innovation Policy 2013
High ratings
• Establishment of CoEs in various
areas; NMITLI initiative on PPP basis
• Increased investments by private
players; setting up of R&D centers
• During FY10–15, increase in
Intellectual Property Rights (IPR)
applications witnessed at a CAGR of
26.9 per cent, with the number
increasing from 79,697 to 262,638
2015E
R&D
spending:
USD66.49
billion
2016F
R&D
spending:
USD71.48
billion
Advantage
India

MARKET OVERVIEW AND TRENDS

EVOLUTION OF INNOVATION AND R&D IN INDIA
Source: Zinnov, Korn/Ferry International, Asia-Pacific Research Center, Stanford University, TechSci Research
Notes: TRIPS - Trade Related Aspects of Intellectual Property Rights, WTO - World Trade Organisation
• Indian Patents and
Designs Act (1911)
• Dependence on bulk
imports
• Establishment of CSIR,
DRDO, ICAR, ISRO and
IITs
• Patents Act (1970)
• Recognition of
process patents
only
• Restricted foreign
ownership in Indian
companies
• Focus on ‘reverse
engineering’ among
pharmaceutical
companies
• TRIPS under WTO
(1995)
• Amendments to the
Patents Act (1970) to
make it TRIPS compliant
• Reintroduction of product
patents
• Reduction in tariff and
non-tariff measures
• Easing FDI norms
• Shifting focus in pharma
towards clinical research
and new drug
development
Before 1970
Introductory Stage
1970 to early 1990s
Indigenization
Stage
Early 1990s to 2005
Liberalization and
Transition Era
2005 onwards
Growth Era
• Augmentation of network of centrally-funded
institutions and universities
• Increase in R&D and exports in sectors such
as IT, pharma, electronics and automobiles
• Innovations in automobiles such as Nano,
the world’s least expensive car
• Numerous innovations from rural India
• Setting up of National Innovation Council
• Adoption of Science, Technology and
Innovation Policy 2013
• In FY15, 42,763 patents were filed in the
country, of which 5,978 were granted
• During April 2000 to March 2016, Cumulative
FDI inflows in the sector reached USD288.63
billion

FORMS OF INTELLECTUAL PROPERTY
Source: Department of Industrial Policy
and Promotion, TechSci Research
Intellectual
Property (IP)
Patents
Trademarks
Geographical
Indications
Industrial
Designs
Layout
Designs
Plant Variety
Protection
Copyright

99DECEMBER 2016
37
51
46
60
71
77
109
167
396
514
Brazil
Russia
United Kingdom
France
India
Souht Korea
Germany
Japan
China
United States
INDIA AMONG THE WORLD’S LEADING R&D INVESTORS
Source: Nature Magazine, Battelle, TechSci Research
Notes: GERD - Gross Domestic Expenditure on R&D,
R&D - Research and Development; 1 - Data is for May 2015;
Expected expenditure of world’s leading R&D
investors in 2016 (USD billion)India’s R&D investments increased to USD71.48 billion in
2016 from USD66.49 billion in 2015.
R&D investments has helped Indian companies to
overcome tight competition with affordable products
internationally
Spending per Researchers1
(in thousands)
342
293
273
238 226 214 202
181 173 171 157 155
58
UnitedStates
Germany
Austria
Italy
Japan
France
SouthKorea
Brazil
China
India
Canada
UK
Pakistan

1010DECEMBER 2016
61.85
66.49
71.48
2014 2015E 2016F
Source: R&D Magazine, International Monetary Fund, World Bank, CIA Fact Book,
OECD, Department of Science and Technology, TechSci Research
Notes: CAGR - Compound Annual Growth Rate, PPP - Purchasing Power Parity,
R&D – Research & Development, E – Expected, F – Forecast
R&D spending in India (USD Billion)India’s share of global R&D spending rose to 3.53 per cent
in 2015 from 3.43 per cent in 2014 and is forecast to be at
3.67 per cent in 2016
As of 2015, on the basis of investment in R&D, India is the
sixth largest country across the globe and the fourth largest
country in Asia. The country’s R&D investment growth is
likely to outpace overall GDP growth by the end of 2018.
In 2015, R&D investments in India was 0.9 per cent of GDP
which would further increase and reach 2.4 per cent by
2034
In developed and emerging economies, the ratio of private
and public sector investments in R&D is generally around
2:1. However, in India, as per recent estimates in 2015,
private sector investments in R&D stand at just about half of
that of the public sector, indicating huge potential for private
players
STRONG GROWTH IN R&D INVESTMENTS IN INDIA OVER THE YEARS

1111DECEMBER 2016
21
38
56
100
125
146
183
249
289
FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16
INDIA HAS BEEN EXPANDING ITS INVESTMENT HORIZON ABROAD
Source: Reserve Bank of India, Department Of Industrial Policy &
Promotion (DIPP), TechSci Research
Cumulative overseas direct investment
(USD billion)
Cumulative overseas direct investments increased to
USD289 billion in FY16 from USD21 billion in FY08, leading
to significant amount of technology transfer through
industrial acquisitions
For instance, Lupin’s total number of patent filing reached
2,525 in FY16 up from 600 in FY08. In FY16, the company
filed 57 formulation patents, 75 API (Active Pharmaceutical
Ingredient) and 33 in the field of biotech.
Out of filed patents, in FY16, the company got approval for
22 formulation patents, 11 API (Active Pharmaceutical
Ingredient) patents and 41 NCE (New Chemical Entity)
patents.
In FY16, the company invested around USD244 million for
R&D.

TRADEMARK APPLICATION ACCOUNT FOR MAJOR SHARE OF IPR APPLICATIONS
Source: Department of Industrial Policy and Promotion, Intellectual Property India
Annual Report 2015-16, (up to
Dec., 2015) TechSci Research
Note: Figures mentioned are as per latest data available
Break-up of Intellectual Property Rights (IPR)
applications (FY16)
During FY2015-16, the total number of Intellectual Property
Rights (IPR) stood at 251,420
Trademark applications accounted for the largest share of
82.70 per cent, with the total number of applications
standing at 207,923 in FY15
Patent and design applications accounted for 14.10 per cent
(35,447 applications) and 3.20 per cent (8,035) share,
respectively
82.70%
14.10%
3.20%
0.01% Trade Mark
Patent
Design
Geographical
Indications

IPR APPLICATIONS TRENDING NORTH
Source: Department of Industrial Policy and Promotion, Intellectual Property India Annual Report 2014-15, TechSci Research
Note: Figures mentioned are as per latest data available* (up to Dec., 2015)
Intellectual Property (IP) applications (‘000)
During FY07–15, increase in Intellectual Property Rights (IPR) applications was witnessed at a CAGR of 4.78 per cent, with the
number of applications increasing from 172,374 in FY07 to 262,590 in FY15.
During FY07-15, the total number of trademark applications increased at a CAGR of 5.4 per cent and reached to 210,501 by the
end of FY15
Patent and design applications rose at a CAGR of 5 per cent and 6.8 per cent respectively, during the same period
Growing IP application activity indicates increased in-house R&D and innovation in India
INNOVATION AND PATENTS35.218
36.812
34.287
39.4
43.197
43.674
42.95
42.763
35.447
6.402
6.557
6.092
7.589
8.373
8.337
8.533
9.327
8.035
123.514
130.172
141.943
179.317
183.588
194.216
200.005
210.501
207.923
0.037
0.044
0.04
0.027
0.148
0.024
0.075
0.047
0.015
2007-08 2008-09 2009-10 2010-11 2011-12 2012-13 2013-14 2014-15 2015-16*
Patents Designs Trade Marks Geographical Indications

1414DECEMBER 2016
721
776
835
872
913 928
955
988
1033
1085
1139
2010 2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F
INDIA IS FAST EMERGING AS A GLOBAL R&D HUB … (1/2)
Source: Zinnov Consulting - Crossing the value chasm, TechSci Research
Notes: CAGR - Compound Annual Growth Rate,
MNC – Multinational Corporations
R&D - Research and Development, E – Estimate, F – Forecast
MNC R&D centers in IndiaThe number of MNC R&D centers in India has grown at a
CAGR of 5.2 per cent from 721 in 2010 to 928 in 2015, with
the total number of MNC R&D centers estimated to reach
955 by the end of 2016
During 2010-15, the workforce in MNC R&D centers
increased at a CAGR of 9.63 per cent and reached 323,000,
which is estimated to further increase to 353,000 by 2016 in
India.
CAGR: 4.7%
204
220
244
268
295
323
353
387
424
464
508
2010 2011 2012 2013 2014 2015 2016E2017F2018F2019F2020F
MNC R&D centers workforce in India
(in 000’)
CAGR: 9.6%

INDIA IS FAST EMERGING AS A GLOBAL R&D HUB … (2/2)
Source: Zinnov Consulting Report 2015, TechSci Research
Notes: CAGR - Compound Annual Growth Rate,
R&D - Research and Development
YoY- Year on Year
Vertical-wise distribution of R&D centers in India
(2015)
Until 2005, Tier-1 cities were the favourite destination for
MNCs due to availability of rich talent, favorable policies,
and better quality of life
However, post-2005, MNCs have started expanding to Tier-
2 cities, as they offer benefits such as higher catchment
area, lower attrition and cost arbitrage
R&D related investments and processes attain easier
approval from regulatory authorities, globally. This has also
increased focus on new generics
India’s R&D ecosystem has grown at a phenomenal pace in
the last ten years. 42% of the Global 500 R&D Spenders
have centers in India, with the figure expected to reach 49%
by 2020
As of 2015, 928 MNCs, with a total of 1165 R&D centers
were operating within the country.
Bangalore and Pune accounted for the highest
concentration of R&D Talent, with around 96% of MNCs
housed in Tier-1 cities.
India has emerged as the most preferred destinations for
innovation in Asia and the third biggest, globally, with
'Silicon Valley' of East Bengaluru leading the charge, says
Capgemini, a research by global consulting major.
13
62
7
39
11
90
18
21
22
57
9
20
4
25
68
302
76
4
0 50 100 150 200 250 300 350
Aerospace & Defence
Automotive
Biotechnology
Chemicals & Materials
Diversified
Electrical & Electronics
Energy
Engineering Services
FMCG
Industrial
Media & Entertainment
Medical Devices
Others
Pharmaceuticals
Semiconductors
Software/ Internet
Telecom & Networking
Travel & Transportation

1616DECEMBER 2016
7.8
15
2015 2020
INDIA IS ALSO GARNERING THE BENEFITS OF R&D OUTSOURCING
Source: Financial Express, Value Notes, TechSci Research
Notes: R&D - Research and Development,
IT - Information Technology; CAGR - Compound Annual Growth Rate;
Engineering R&D outsourcing in India
(USD Billion)
Companies across sectors (such as IT, consumer electronics,
personal devices, medical electronics, telecom and
automobiles) are now offshoring complete product responsibility
India has become one of the most preferred location for
engineering offshoring
By 2020, USD42 billion worth of work related to R&D of product
engineering is expected to be outsourced to India, growing by a
CAGR of 22.7 per cent from 2003
The outsourcing R&D services market in India is expected to
reach USD38 billion by 2020 from USD20 billion in 2015.
Newer capabilities such as supply chain, regulatory
compliances and manufacturing engineering are being
developed by Engineering R&D Service providers
Service providers in Europe are increasingly looking at scaling
up and setting offshore operations in India to access cost
effective large talent pool
CAGR: 14%

GLOBAL 500 COMPANIES PRESENCE IN INDIA
Source: Zinnov – Crossing the value chasm, TechSci Research
Notes: R&D - Research and Development
1 – Data is up to Dec 2015,
2 – Data is up to September 2015,
3 - Data is for FY15
Number of R&D centers for global 500 companies,
2014
The top 500 R&D spenders contribute over USD614 billion with the
top 100 R&D spenders alone contributing 66 per cent to the global
R&D spend
In FY15, most of the leading pharma players spent anywhere
between USD58-325 billion on R&D, which represented an increase
both in absolute term as well as in proportion to net revenues (8-11
per cent of sales)
More than one-third of the top 1,000 global R&D spenders have
centres in India. Around 50 per cent of the global 500 companies
present have more than 10 per cent of the global headcount in
India
During 2015, 40 per cent of the overall R&D globalisation, valuing
USD12.3 billion was based out of India. 69 per cent of the new
offshore technology centres are being setup in the country
46
83
52 45
28 20
4
17
48 55
72 80
Top 50 Top 100 100- 200 200-300 300-400 400-500
Present Not present
R&D spending by top six pharma giant FY16
(USD million)
352
272.44
244
158.16
104.03 102
71.79
Sun
Pharma
Dr Reddy Lupin Cipla Cadila Wockhardt Aurobindo

Encouraging the private
sector
• The benefit of section 10 (23 G) of the IT Act has been extended to financial institutions
that provide long-term capital to hospitals with 100 beds or more
• Government is encouraging the PPP model to improve availability of healthcare services
and provide healthcare financing
Encouraging
investments in rural
areas
• The benefit of section 80-IB has been extended to new hospitals with 100 beds or more
that are set up in rural areas; such hospitals are entitled to 100 per cent deduction on
profits for five years
• Under Union Budget 2016-17, government allocated USD130 million to encourage
farmers to opt for allied activities
• In Union Budget 2016-17, the government, under the Accelerated Irrigation Benefit
Programme (AIBP), would ensure to complete 23 irrigation projects before March 2017
Source: Union Budget 2014-15, Union Budget 2015-16,
Union Budget 2016-17, Health Ministry, TechSci Research
STRONG POLICY SUPPORT CRUCIAL IN DEVELOPING THE SECTOR
Tax incentives
• As per Union Budget 2015-16, custom duty on life-saving equipment has been reduced to
5 per cent from 25 per cent and have been exempted from the purview of countervailing
duty
• Import duty on medical equipment has been reduced to 7.5 per cent
• As per Union Budget 2016-17, services provided by National Centre for Cold Chain
Development (NCCD) would be exempted from service tax
Incentives in the medical
travel industry
• Incentives and tax holidays are being offered to hospitals and dispensaries providing
health travel facilities
Policy Landscape
• India released a new national Intellectual Property Rights Policy, which seeks to enhance
Prime Minister Narendra Modi’s - Make in India scheme, by boosting innovation.

1919DECEMBER 2016 For updated information, please visit www.ibef.orgSource: Intellectual Property India Annual Report 2014-15
Top 5 Indian Applicants for patents in the field of Information
Technology
S.No. Name of the Company
Application
Filled
1
Samsung R&D Institute India-
Bangalore Private Limited
233
2 Tata Consultancy Services Limited 147
3 Wipro Limited 117
4 Hindustan Aeronautics Limited 57
5
Indian Institute of Technology
(Collective)
50
Top 5 Indian Applicants For Patents from Science and
Research & Development Organizations
Application
Filled
1
Council of Science & Industrial
Research
315
2
Director General, Defence Research
& Development Organization
98
3
Indian Council of Agricultural
Research
68
4 G,H.R. Labs and Research Centre 31
5 Department of Biotechnology 23
Top 5 Indian Applicants for patents from Institutes and
Universities
Application
Filled
1 Indian Institute of Technology (Collective) 337
2
Janardan Rai Nagar Rajasthan
Vidyapeeth (Deemed) University
53
3 Indian Institute of Science 46
4 Amity University 43
5
Sandeep Foundation’s Sandip Institute of
Technology & Research Centre
33
Top 5 Foreign Applicants
S.No. Name of the Company Application Filled
1 Qualcomm incorporated 1214
2 Koninklijke Philips N.V. 805
3
Telefonaktiebolaget LM
Ericsson (PUBL)
449
4 Samsung Electronics Co. Ltd 379
5 BASF SE 297
INCREASING IN THE PATENT APPLICATION FILING (FY15)…..(1/2)

INCREASING IN THE PATENT APPLICATION FILING (FY15)…..(2/2)
Top 5 Indian Patentees
Application
Filled
1
Council of Scientific & Industrial
Research
66
2 Bharat Heavy Electricals Limited 56
3
Samsung R&D Institute India
56
4
(Collective)
30
5 Tata Motors Limited 26
Top 5 Foreign Resident Patentees
Application
Filled
1
GM Global Technology Operations
Inc.
267
2 Qualcomm Incorporated 205
3
Telefonaktiebolaget LM Ericsson
(PUBL)
94
4 LG Electronics Inc. 87
5 Koninklijke Philips Electronics N.V. 61
Source: Intellectual Property India Annual Report 2014-15

KEY PLAYERS IN R&D - SCIENTIFIC AND R&D ORGANISATIONS1 … (1/2)
Source: Organisational websites, IP India, TechSci Research
Notes: R&D - Research and Development; IP – Intellectual Property, 1 - This list is indicative
Organisation Business description
Council of Scientific and Industrial Research (CSIR)
• CSIR is India’s largest R&D organisation, with 38 national laboratories, 39 outreach centers, 3 Innovation
Complexes, 5 units, 4600 active scientists supported by about 8000 scientific and technical personnel. On an
average CSIR files about 200 Indian patents and 250 foreign patents per year. About 13.86% of CSIR patents are
licensed, a number which is above the global average. It is engaged in scientific industrial R&D for economic,
environmental and societal benefits for the country
• Its research areas span across aerospace, biotechnology, chemicals, energy, foods, information dissemination,
leather and metals, minerals and manufacturing etc.
• CSIR is ranked at 84th among 4851 institutions worldwide and was the only Indian organisation among the top 100
global institutions in 2014. CSIR filed 315 patent application in FY15.
Defence Research and Development Organisation (DRDO)
• DRDO is engaged in design and development of weapon systems and equipment in accordance with the
requirements of the military services
• DRDO had a network of 50 labs and establishments to carry out research. It has over 5,000 scientists and about
25,000 other scientific, technical and supporting personnel. DRDO has filed 98 patent application in FY15.
• Its research areas include aeronautics, armaments, combat vehicles, electronics, instrumentation engineering
systems, missiles, materials, naval systems, advanced computing, simulation and life sciences. In June 2015,
DRDO’s ballistics test facility got inaugurated in Ramgarh.
Indian Council of Agricultural Research (ICAR)
• ICAR is one of the largest national agricultural organisations in the world. It consisted of 99 institutes and 53
agricultural universities across India. ICAR has filed 68 patent application in FY15
• It is the apex body for coordinating, guiding and managing research and education in agriculture, including
horticulture, fisheries and animal sciences in India.

2222DECEMBER 2016
KEY PLAYERS IN R&D - SCIENTIFIC AND R&D ORGANISATIONS1 … (2/2)
India Space Research Organisation (ISRO)
• ISRO is engaged in development of space technology and its application to various national tasks, launched
Mangalyan successfully in its very first attempt
2
. In FY5, ISRO filed 13 patent application
• The organisation has 19 centers across India to pursue R&D activities and ISRO currently has a constellation of 9
communication satellites, 1 meteorological satellite, 10 earth observation satellites and 1 scientific satellite
• Its research areas include communication satellites for television broadcast, telecommunications and
meteorological applications, and remote sensing satellites for management of natural resources
• On June 22, 2016, ISROs Polar Satellite Launch Vehicle, PSLV-C34, successfully launched 20 satellites in a single
flight
Indian Council of Medical Research (ICMR)
• ICMR is the apex body in India for the formulation, coordination and promotion of biomedical research and one of
the oldest medical research bodies in the world. ICMR has filed 14 patent applications in 2014.
• The council has a fleet of 21 institutes (mission oriented national institute), six regional medical research centers
and five units engaged in medical research
• The council’s research priorities encompass the areas of communicable diseases, fertility control, maternal and
child health, nutritional disorders, and non-communicable diseases such as cancer, cardio-vascular diseases,
blindness and diabetes
Centre for Development of Advanced Computing (C-DAC)
• C-DAC is a premier R&D organisation of the Department of Information Technology (DIT)
• It is engaged in research in the areas of supercomputers, applied electronics, technology, applications and health
informatics
• C-DAC filed 20 patent applications in FY15
Source: Organisational websites, TechSci Research
Notes: R&D - Research and Development,
1 - This list is indicative, 2 - as on 24 September 2014

KEY PLAYERS IN R&D - INSTITUTES AND UNIVERSITIES1 … (1/2)
Indian Institutes of Technology (IITs)
• It is a group of autonomous engineering and technology oriented institutes of higher education
• Indian Institutes of Technology (IITs) is planning to monetise intellectual properties (IPs) by exploring tie-ups with
firms that invest in "inventions". In FY15, IITs filed 337 patent application.
National Dairy Research Institute (NDRI)
• NDRI is engaged in research, teaching and extension activities in areas of dairy production, processing,
management and human resource development
• Its research activities focus on improving dairy productivity, innovating milk processing technologies and
disseminating information to the various stakeholders in dairy business to make dairying a self-sustaining business
• In 2014, R&D activities comprised 89 in-house and 74 externally funded research projects, including 19 NAIP
projects in consortium mode with financial outlay of USD21.95 million. In FY16 NDRI filed 4 patents.
Indian Institute of Science (IISc)
• IISc is one of the earliest instances of PPP for a research institute in India
• It is engaged in research in various departments of science such as biological, chemical, electrical, mathematical,
physical and mechanical sciences. A new center for Brain Research is expected to contribute to future growth
• The number of filed patents increased to 46 during FY15.
Source: Organisational websites, IP India, TechSci Research
Notes: R&D - Research and Development, IP - Intellectual Property,1 - This list is indicative

KEY PLAYERS IN R&D - INSTITUTES AND UNIVERSITIES1 … (2/2)
The Energy and Resources Institute (TERI)
• TERI is engaged in developing solutions to global problems in fields of energy, environment and sustainable
development, has also established research centers in Bengaluru, Goa, Guwahati, Himalayas, Mumbai
• The important research areas include biotechnology, earth science and climate change, technology development,
social transformation, and modelling and economic analysis
• Deals in various sector projects such as Agriculture, Coal, Energy, Environment, Industry, Renewable Energy,
Information and Communication Technology, Rural Development, Climate Change, Economy, Forestry and
Biodiversity and etc.
• On 3
rd
December, 2015 TERI reveals the ‘Corporate Vision on Climate Change’ at 21
st
Conference of the Parties
(COP 21)
Institute of Life Sciences (ILS)
• ILS undertakes basic and translational research in frontier areas of life sciences
• The institute’s research interests are in the areas of infectious disease biology, gene function and regulation, and
translation research and technology development
Indian Institute for Advanced Studies (IIAS)
• IIAS is a residential centre for advanced research in humanities, social sciences and natural sciences
• Its major research areas include social, political and economic philosophy; comparative studies in philosophy and
religion; education, culture and arts; natural and life sciences; and national integration and nation building
Notes: R&D - Research and Development, 1 - This list is indicative

KEY PLAYERS IN R&D - PRIVATE SECTOR COMPANIES1
Hindustan Unilever Limited
• HUL is credited with innovations in product areas such as structured bar soap, fairness cream, zero alcohol soap,
poly-coated scouring bar for dishwashing, fortified salt, instant tea, critical components for a water purifying device,
and value-added (nature care) tea
• Worldwide, HUL has over 20,000 registered patents and patent applications
• HUL expenditure on scientific research and development is around USD6.05 million in FY16, where the total
revenue expenditure is USD5.67 million and USD0.38 million expenditure made as a capital expenditure
Tata Steel Limited
• Tata Steel undertakes research in areas such as raw materials and coke, iron and ferro alloys, steel making,
coated products, materials characterisation and joining, materials modelling and product design, and refractory
technology
• The total value of the patent is around USD16.65 million till FY16.
• The total patents filed was 71 and 32 patents were granted as on FY16.
Cipla Limited
• Cipla’s R&D division focuses on new product development and new drug delivery systems across a range of
therapies
• The company’s total R&D spending increased and reached USD158.16 million in FY16
• In 2015, Cipla filed more than 200 formulation development projects underway. Company filed 12 formulation in
north America, 78 in Europe region while more than 1800 internationally
• It is among the top companies domestically in R&D spending
Notes: R&D - Research and Development, Growth, 1 - This list is indicative

Source: Times of India, Economic Times, The Hindu, Defence Now
Notes: ICBM - Inter-Continental Ballistic Missile, DRDO - Defence Research & Development Organisation,
HSL - Hindustan Shipyard Limited, LCA – Light Combat Aircraft
INNOVATION HAS BEEN A CORNERSTONE OF THE COUNTRY’S DEFENCE SECTOR
INS Vikrant
• India Indigenous
Aircraft Carrier (IAC)
• Total displacement
of over 40,000
tonnes
• Being built by
Cochin Shipyard
Limited
• Expected to be
Commissioned in
2017
Agni-V missile
• Successfully test
fired in April 2012
• India joined an elite
group of nations
having ICBM
technology
• Indigenously
developed by DRDO
• To be inducted by
2016 after few more
trials
Arihant Class
Submarines
• With its launch in
2009, India joined
an elite group of
nations having
nuclear-powered
submarines
• Developed by HSL
Tejas
• Second supersonic
aircraft to be
developed
indigenously by
Hindustan
Aeronautics Limited
(HAL)
• In July 2016, LCA
Tejas aircraft was
inducted into the
Indian Air Force

PORTERS FIVE FORCES ANALYSIS –
HEALTHCARE & BIOTECHNOLOGY

PORTERS FIVE FORCES ANALYSIS – HEALTHCARE
Source: TechSci Research
Note: R&D – Research and Development
Competitive Rivalry
• In a bid to discover the next block buster drug, competition between
the pharma companies are intense
• In addition, expiry of patents will also lead to further competition from
generic drug manufacturers
Threat of New Entrants Substitute Products
Bargaining Power of Suppliers Bargaining Power of Customers
• Huge R&D expenditure
requirement reduces threat of
new entrant
• Government regulation is strict
for this industry
• Bargaining power of suppliers
in this industry is high because
quality of products and timely
delivery matter and there is less
number of quality suppliers in
this industry
• Bargaining power of customers
is low due to undifferentiated
products
• Cheaper generic formulations
pose a threat to healthcare
companies
Competitive
Rivalry
(High)
Threat of New
Entrants
(Low)
Threat of
Substitute
Products
(Low)
Bargaining
Power of
Customers
(Low)
Bargaining
Power of
Suppliers
(High)

PORTERS FIVE FORCES ANALYSIS – BIOTECHNOLOGY
Competitive Rivalry
• High entry barriers due to the capital-intensive nature of the industry
has reduced competitive rivalry
• Entry of new players in the market has led to increased competition.
However, given the low success rate, rivalry is low
Threat of New Entrants Substitute Products
Bargaining Power of Suppliers Bargaining Power of Customers
• Capital intensive nature of
industry reduces the threat of
new entrants
• Strict government regulation
• Suppliers’ power is low
because the raw materials are
largely undifferentiated
• Individual buyers do not have
influence on pricing
• However, government price
control enhances buyer’s
power
• Patent protection stops the
threat of alternative drugs and
chemicals for a period of time
Competitive
Rivalry
(Moderate)
Threat of New
Entrants
(Low)
Substitute
Products
(Low)
Bargaining
Power of
Customers
(Low-Moderate)
Bargaining
Power of
Suppliers
(Low)

STRATEGIES ADOPTED –
HEALTHCARE & BIOTECHNOLOGY

STRATEGIES ADOPTED – HEALTHCARE
Source: Company website, TechSci Research
• Private players in the industry are making their supply chain efficient and leveraging
economies of scope to reduce cost. One such example is Narayan Hrudayalaya (NH) where
health care is provided at affordable cost. NH reduces cost by
• High procurement of medical supplies
• High-volume by high capacity utilisation and staff productivity
• Good human capital management (i.e. training)
• Leveraging the benefit of Information Technology to reduce cost and improve healthcare
delivery
• Developing new and innovative healthcare services will help players in differentiating
themselves from others
• Healthcare providers are also trying to provide better services to differentiate themselves
• Players in Healthcare sector are heavily spending on R&D. For example, in 2016, Novartis
opened a major R&D center in Shanghai, China worth USD1 billion
• Sun Pharma is focusing on specialty and chronic therapies such as neurology, oncology,
dermatology, rather than competing in anti infective and gastrointestinal therapies markets.
Sun Pharma attained volume and value leadership in many of these therapies
• Certain players in industry focus only on providing one kind of health care service to its
customers and gain expertise through research in the area. This also helps them to be the
leader in that service. One such example is Tata Memorial Hospital which is focused on
treatment of cancer and provides leading cancer treatment in India
Cost leadership
Differentiation
Focus

STRATEGIES ADOPTED – BIOTECHNOLOGY
Source: Company website, TechSci Research
Notes: R&D – Research and Development
• Higher emphasis on technological innovations that will improve efficiency and help in
achieving cost leadership. For example, Serum Institute of India is the leader in
manufacturing vaccines against Rubella, Tetanus, Measles and Diphtheria and it supplies
vaccines to more than 100 countries across the globe. Due to high volume sales the
company has relatively low manufacturing cost
• Investing heavily on R&D to create new and innovative products. Biocon has subsidiaries,
Syngene International Limited and Clinigene International Limited, these companies have
been set up to focus on clinical trials, drug discovery and development.
• Companies are creating barriers by applying for patents to curb replication of the drug by
other manufacturer. For example, until March 2016, Panacea filed over 1,500 patent
applications, including 230 in India
Cost leadership
Differentiation
Creating barriers

GROWTH DRIVERS

STRONG DEMAND AND POLICY SUPPORT DRIVING INVESTMENTS
Source: Battelle, Electronics for You, Organisational websites, TechSci Research
Notes: PPP - Public Private Partnership, R&D - Research and Development,
NMITLI - New Millennium Indian Technology Leadership Initiative,
CoE - Centre of Excellence, NIC - National Innovation Council
Policy support
PPP in R&D
Strengthening
educational
infrastructure
Amendments to the
Patents Act &
Setting up of NIC
Inviting Resulting in
Growing demand
Evolving consumer
lifestyles
Liberalisation and
increasing competition
Proximity to future
growth markets
Increasing investments
Establishment of
CoEs, NMITLI initiative
Providing support to
global projects from
India
Increasing corporate
R&D investments

PHARMACEUTICAL SECTOR DRIVING R&D GROWTH
R&D spending by top six Pharma giants in FY16
(USD million)
India’s pharmaceutical market is highly fragmented, with
300 large and 18,000 mid-sized and small companies
The country’s pharma industry accounts for about 1.4 per
cent of the global pharma industry in value terms and 10 per
cent in volume terms
Indian healthcare sector, one of the fastest growing
industry, is expected to advance at a CAGR of 17 per cent
during 2011–20 to reach USD280 billion
This would help drive R&D growth in India; the average
R&D expenditure by Indian pharma companies is close to 6
per cent of total revenues
352
272.44
244
158.16
104.03 102
71.79
Sun
Pharma
Dr Reddy Lupin Cipla Cadila Wockhardt Aurobindo

POLICY SUPPORT AIDING GROWTH IN THE SECTOR … (1/2)
PPP in R&D
• Exchange of scientific knowledge between research centers, national laboratories,
institutes of higher learning and the industry
• The Indian Government plans to involve the private sector in R&D mainly for sectors like
vaccines, drugs and pharmaceuticals, super computing, solar energy and electronic
hardware. The govt. has announced to create a USD16 million fund for setting up R&D
units with the help of industries
• The government has created a USD1.1 billion public-private partnership fund to support
research and development in India
Funded institutions and
foreign universities
• Government has announced to set up 5 new All India Institute of Medical Sciences in
Jammu & Kashmir, Punjab, Tamil Nadu, Himachal Pradesh, Assam and set up of IIT in
Karnataka and Dhanbad
• Foreign universities permitted to enter the higher education system in India by establishing
their own campuses or joint ventures with existing universities
• Atal Innovation Mission with USD24.84 million will boost the academicians, Entrepreneurs
and researchers to work towards innovation
Science & Technology
• In Union Budget 2016-17, Government of India has announced its plans to make 10 public
and 10 private institutions as world class teaching & research institutes
• In Union Budget 2016-17, Government has allotted USD260 million for establishing 1500
multi-skill development centers
Source: Battelle, Electronics for You, Union Budget 2015-16,
Organisational websites, TechSci Research
Note: PPP - Public Private Partnership

POLICY SUPPORT AIDING GROWTH IN THE SECTOR … (2/2)
National Innovation
Council (NIC)
• In 2010, NIC was set up to implement strategies for inclusive innovation in India and
prepare a roadmap for innovation over 2010-20, idea is to build a domestic model to cater
to Indian needs
• Tasks of NIC include creating a framework to encourage innovation by central and state
governments, universities, R&D institutions and SMEs
• NIC build digital database of innovations across sectors and at grassroot. In addition NIC
has also set up sectorial Innovation council in Maharashtra
• NIC and the Ministry of Micro, Small and Medium Enterprises (MSME) jointly created India
Inclusive Innovation Fund (IIIF), currently IIIF investment limit is restricted to USD82
million and it invests in sectors like healthcare, water, energy and agriculture.
Source: Battelle, TechSci Research
Note: SMEs - Small and Medium Enterprises
Atal Innovation Mission
• Atal Innovation Mission (AIM) established in NITI Aayog with initial funding worth
USD24.56 million for promotion of research and development sector. The mission aims at
providing innovation promotion platform to academicians, entrepreneurs and researchers.
• Atal Innovation Mission would provide the framework to government for encouraging and
promoting self employment in Indian youth
Patents (Amendment)
Rules, 2016
• The time limit for filing response to First Examination Report (FER) has been reduced to 6
months.
• With a maximum of two adjournments hearings can now be conducted through video
conferencing as well as audio visual communication devices.
• Maximum fees for sequence listings would be USD1850, wherein, cost per page would be
almost USD12.

SCIENCE TECHNOLOGY AND INNOVATION (STI) POLICY 2013
Introduction of STI
Policy 2013
• In January 2013, the Government of India introduced the Science, Technology and
Innovation (STI) policy 2013 at the centenary sessions of the Indian Science Congress
held at Kolkata
Vision of STI Policy
• The STI policy is aimed at helping India become one of the top five global scientific
powers by 2020, by taking advantage of large demographic pool of engineers and science
graduates
Rising involvement of
the private sector
• STI aims to boost innovation through Research and Development (R&D) led by the Public-
Private Partnership (PPP) mode thereby increase the investments on Research and
Development (R&D) to 2 per cent of GDP by 2017 from current 1 per cent
Increase in human
resources
• The policy seeks to increase the number of full-time R&D personnel by 66 per cent over
2013–17 and expand the number of publications from the current 3.5 per cent of global
share to around 7 per cent by 2020

RECENT INVESTMENTS IN R&D BY KEY PLAYERS
Source: India Electronic News, Moneycontrol, CNBC, Economic Times, Appliancemagazine.com,
Business Standard, The Hindu, Company websites, TechSci Research
Note: R&D - Research and Development
2013
• Jan 13: DuPont has double
their R&D activities in India
• April 13: Yamaha
announced the
establishment of a R&D
centre in India
• Jun 13: Huawei has set up
a new Research and
Development (R&D) centre
in Bengaluru with an
investment of USD150
million
• Jul 13: OneOcean
Corporation has set up
ClipCard Technology
(R&D) centre in India
• Oct 13: Carraro India has
set up a new R&D centre in
India
• Jan 22: Intel India to invest
over USD120 million to
expand its Bengaluru R&D
center
• Mar 07: BASF opens global
R&D center in Mumbai
• Sep 10: Valvoline
Communications Ltd (VCL)
a JV between Ashland Inc
and Cummins India Ltd will
open its R&D centers in
Ambernath near Mumbai in
Maharashtra
20142015
• August 2015: Foxconn
announced to invest USD5
billion in India over next five
years to set up R&D
centers and manufacturing
plants
• May 2015: Ford Motor
company have announced
to invest around
USD829.46 million in R & D
center Chennai
• July 2015: Lupin, has
decided to invest
USD185.63 million in the
pharma sector.
2016
• May 2016: Royal Enfield
announced its plans to
invest USD91.7 million in
setting up 2 new R&D
centers, one of which would
be setup in Chennai, in
FY17
• Mar 2016: Daikin, under
Make in India initiative, is
planning to invest around
USD91 billion to establish
R&D centre and a
manufacturing unit in
Rajasthan
• Feb 2016 - Ferring Holding
SA, Switzerland-based
pharma research company,
planned to set a R&D
centre in Hyderabad worth
USD250 million

RECENT INVESTMENTS IN R&D BY GOVERNMENT
Source: India Electronic News, Moneycontrol, CNBC, Economic Times, Union Budget,
Appliancemagazine.com, Business Standard, The Hindu, Company websites, TechSci Research
Note: R&D - Research and Development
NMITLI-New Millennium Indian Technology Leadership Initiative
Centers of Excellence
(CoEs)
• In 2015, National
Association of Software
and Services Companies
(NASSCOM), Department
of Electronics &
Information Technology
(DeitY) and Education and
Research Network
(ERNET) jointly has
formed Center of
Excellence with the seed
funding done by
government.
• COEs are generally run on
PPP model
• CoEs have been set up in
the areas of telecom,
wireless technology, bio-
informatics, lasers and
optoelectronic devices and
nano-electronics
NMITLI
• The programme identifies
areas for development
based on national
consultation and invites
best partners from
institutions, academia and
private sector to play a role
in the process
• NMITLI have received a
budgetary allocation of
USD4.91 million under the
Union Budget 2015-16. It
has initiated 60 largely
networked projects in
diverse areas involving 85
industry partners and 280
R&D groups from different
institutions with investment
outlay of USD114 million
Centrally funded institutes
Central and foreign
universities
• New universities in 16
uncovered states
• The remaining 14 new
Central Universities will be
set up as world class
centers of excellence at
different locations
• Foreign universities can
enter higher education
system in India by having
their own campuses or joint
ventures with existing
universities
• 12 teacher education
courses and three new
programmes have been
upgraded
• In Union Budget 2015-16,
Government of India has
announced to set 5 new
AIMS, 2 new IITs and 2 IIMs
• These institutes together
account for over 80 per cent
of the total PhDs in
engineering in India
• The institutes are also
amongst the top Indian
applicants for patents from
the ‘institutes and
universities’ category
• In Union Budget 2016-17,
government has announced
to make 10 public and 10
private institutions as world
class institutes

OPPORTUNITIES

Source: ARAI, Business Standard, India Law Office, Deloitte, TechSci Research
Notes: IT - Information Technology, ARAI - Automotive Research Association of India,
NVH - Noise, Vibration and Harshness, ANDA – Abbreviated New Drug Application,
US FDA – United States Food and Drug Administration
Pharma and healthcare
• Indian healthcare sector, one of the fastest growing industry, is expected to advance at a
CAGR of 22.87 per cent during 2015–20 to reach USD280 billion
• Contract research is one of the fastest growing segment in the Indian healthcare industry.
CRAMS industry is estimated to reach USD18 billion in 2018 and expected to witness a
strong growth at a CAGR of 18-20 per cent during 2015-18
• Indian pharmaceuticals market is estimated to reach around USD30 billion in 2015. The
country’s pharmaceutical industry is expected to expand at a CAGR of 12.89 per cent over
2015–20 to reach USD55 billion
• The number of ANDA approvals granted by US FDA increased from 109 in FY15 to 201 in
FY16 to the Indian companies
Information Technology
(IT)
• India is seen as a product development destination
• Companies are offshoring their product responsibilities including complex services like
product management
• NASSCOM of India signed IoT Innovation Agreement with Georgia Tech.
Automobiles
• Research is being carried out by individual companies as well as industry associations
such as ARAI in various areas such as structural dynamics, safety, NVH and electronics
• India is the sixth largest auto market in the world and is poised to become the third largest
by 2020
OPPORTUNITIES (1/2)

Source: ARAI, Business Standard, Planning Commission,
India Law Office, TechSci Research
Notes: IT - Information Technology, ARAI - Automotive Research Association of India,
NVH - Noise, Vibration and Harshness, DBT – Department of Biotechnology
Biotechnology
• By FY25, India’s biotech industry is estimated to increase to USD100 billion from USD7.0
billion in FY15
• Protein and antibody production, and fabrication of diagnostic protein chips are promising
areas for investment
• Stem cell research, cell engineering and cell-based therapeutics are other areas, wherein
India will cash in its expertise
Agriculture
• India has the potential to become a major producer of transgenic rice and several
Genetically Modified (GM) or engineered vegetables
• Hybrid seeds, including GM seeds, represent new business opportunities in India based
on yield improvement
• According to International Service for the Acquisition of Agri-Biotech Applications, India
has the fourth largest area covered under genetically modified crops
• In India, 11.57 million hectares of area is covered under genetically modified crops which
is majorly dominated by Bt cotton.
• In 12th Five-Year Plan, DBT has proposed to support 10 agricultural universities through
R&D grants to promote R&D on agriculture
• In Union Budget FY17, the government, under the Accelerated Irrigation Benefit
Programme (AIBP), would ensure to complete 23 irrigation projects, before March 2017
OPPORTUNITIES(2/2)

Source: Zinnov - Crossing the value chasm
Notes G500 – Global 500 companies
OPPORTUNITIES OF JOB CREATION BY GLOBAL 500 COMPANIES
There is a potential to create 200,000 R&D jobs by global
500 companies in the next five years
During 2013-18, R&D headcount is expected to increase at
a CAGR of 15.8 per cent
Around 50 per cent of the global 500 companies present
have more than 10 per cent of the global headcount in India
Talent pool for R&D in the country is expected to grow at a
CAGR of 10.9% from present 0.6 million to 1 million by
2020.
928 MNCs and 1165 R&D centers together employ 55 per
cent of Indias total R&D installed talent base. The workforce
is expected to increase to 0.52 million by 2020
Software/Internet domain account for over 37% of the total
MNC R&D installed workforce
176
366
313
229
489
595
2013 2018
R&D headcount Remaining addressable population
R&D headcount by G500 (‘000)
R&D Talent Distribution
6,10,000
10,20,000
2015 2020
CAGR: 11%

SUCCESS STORIES

4646DECEMBER 2016
38
26
75
42
60
108
45
57
26
84
42
12
41
39
58
75
5
14
17
43
47
232
314
41
FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16
Formulation Patents API/Process Patents NCE Patents
Source: Lupin website, Lupin Reports
Notes: API - Active Pharmaceutical Ingredient, CNS - Central Nervous
System, NSAIDS - Non-Steroidal Anti-Inflammatory Drugs,
TB - Tuberculosis, NCE - New Chemical Entity
Patents filed by LupinLupin is a renowned pharma player having a wide range of
quality, affordable generic and branded formulations and
APIs
Lupin has emerged as the fifth largest and among the top
five fastest-growing companies in the US
It is one of the world’s largest manufacturers of TB drugs
and has significant market share in the cardiovascular,
diabetology, asthma, paediatrics, CNS, Anti-infectives and
NSAIDs therapy segments
By FY16, Lupin’s total patent filing reached 2,525 up from
600 in FY08
The company is amongst the fastest growing in top 10
generic pharmaceutical players in Japan and South Africa
LUPIN: ON A HIGH GROWTH PATH … (1/2)

4747DECEMBER 2016
822.5
1006.7
1250.9
1484.6
1742.1
1839.2
2090.2 2093.1
LUPIN: ON A HIGH GROWTH PATH … (2/2)
Source: Lupin website
Notes: CAGR - Compound Annual Growth Rate
Lupin net sales (USD million)Its revenues increased from USD822.5 million in FY09 to
USD2.09 billion in FY16, at a CAGR of 14.3 per cent
Lupin’s domestic formulations business grew by 6.6 per
cent recording revenues of USD518.1 million for FY16 in
comparison with USD486.1 million for FY15
CAGR: 14.3%

INFOSYS: NURTURING INNOVATION IN IT … (1/2)
Indian IT patent applications ( FY15)Infosys has 3rd highest number of patents applications in India
Research activity for different areas is allocated amongst
dedicated labs such as Software Engineering lab, Convergence
lab, Security and Privacy lab, Distributed Computing lab and E-
Com lab
During FY11-16, the company’s revenues increased at a CAGR
of 9.6 per cent to USD9.5 billion in FY16 from USD6.0 billion in
FY11
During the same period, net profit expanded at a CAGR of 6.4
per cent to USD2.05 billion in FY16 from USD1.5 billion in FY11
Infosys spent USD58.7 million in R&D expenses during FY16
As of November 2016, Infosys through its innovation fund
invested USD 2.17 million in UNSILO, a Danish-based artificial
intelligence start up
Source: Office of the Controller General of Patents,
Designs and Trademarks Annual Report, Intellectual Property India Annual
Report 2014-15, Company Annual Reports, TechSci Research
Income and net profit (USD billion)
6
6.9
7.4
8.2
8.7
9.5
1.5
1.7 1.7 1.8
2 2.05
0
0.5
1
1.5
2
2.5
0
2
4
6
8
10
FY11 FY12 FY13 FY14 FY15 FY16
Sales Net Profit
50
57
117
147
233
(Collective)
Hindustan Aeronautics Limited
Wipro Limited
Tata Consultancy Services Limited
Samsung R&D Institute India-

4949DECEMBER 2016
6
6.3
8.2
10.4
11.6
13.6
15.7
16.6
1.1
1.5
2
2.2
2.6
3.2 3.3
3.7
0
0.5
1
1.5
2
2.5
3
3.5
4
0
2
4
6
8
10
12
14
16
18
Sales Net Profit
TCS: NURTURING INNOVATION IN IT… (2/2)
Source: Company Annual Reports, TechSci Research:
Note: CAGR - Compound Annual Growth Rate
Sales and net profit (USD billion)During FY09–16, the company’s revenues increased at a
CAGR of 15.6 per cent, reaching USD16.6 billion in FY16
from USD6 billion in FY09
During the same period, net profit expanded at a CAGR of
18.9 per cent to USD3.7 billion from USD1.1 billion
TCS spent USD171.3 million in R&D and innovation
expenses during FY16, out of which total sum spent on
R&D was USD36.2 million in the same year

5050DECEMBER 2016
19
22
34.4
20.7
15.1
10.2 8.8
FY10 FY11 FY12 FY13 FY14 FY15 FY16
HUL: A LEADING INNOVATOR IN FMCG
Source: Economic Times, Company Annual Reports,
Company website, TechSci Research
Notes: CAGR: Compound Annual Growth Rate,
20161 – Data as on August 2016
Strong research and development (USD million)Incorporated in 1933, HUL is India’s leading company by
sales in the Fast-Moving Consumer Goods (FMCG) sector
in India. British-Dutch company Unilever owns a majority
stake of 52 per cent in HUL
HUL has won the top FMCG award at the Dun & Bradstreet
Corporate Awards 2015
Hindustan Unilever Limited (HUL) has been ranked No 31 in
India on the Forbes list of Most Innovative Companies
across the globe for 20161.
The company has over 20,000 registered patents and
patent applications worldwide
HUL is also driving innovation in various categories such as
oral care, personal products and soaps & detergents etc.
CAGR: 2.89%

USEFUL INFORMATION

5252DECEMBER 2016
INDUSTRY ASSOCIATIONS
Automotive Research Association of India (ARAI)
Survey No 102, Vetal Hill, Off Paud Road, Kothrud,
Pune - 411 038
Tel: 91-020 30231111
Fax: 91-020 25434190
E-mail: info@araiindia.com
Website: www.araiindia.com
Indian Society for Clinical Research (ISCR)
c/o Pfizer center, 5, Patel Estate, S.V.Road, Jogeshwari(West),
Mumbai-400 102
Tel: 91-022 26774140, 66932028
E-mail: info@iscr.org
Website: www.iscr.org
The South India Textile Research Association (SITRA)
13/37, Avanashi Road, Coimbatore - 641 014
Tel: 91-422 2574367, 6544188
Fax: 91-422 2571896
Email: sitraindia@dataone.in
Website: www.sitra.org.in

5353DECEMBER 2016
GLOSSARY … (1/2)
API: Active Pharmaceutical Ingredient
ARAI: Automotive Research Association of India
CAGR: Compound Annual Growth Rate
CoE: Center of Excellence
DRDO: Defence Research and Development Organisation
FDI: Foreign Direct Investment
FY: Indian Financial year (April to March)
So FY10 implies April 2009 to March 2010
GDP: Gross Domestic Product
GERD: Gross Domestic Expenditure on Research and Development
HAL: Hindustan Aeronautics Limited
HSL: Hindustan Shipyard Limited

5454DECEMBER 2016
GLOSSARY … (2/2)
IAC: Indigenous Aircraft Carrier
ICBM: Intercontinental Ballistic Missile
IT: Information Technology
NMITLI: New Millennium Indian Technology Leadership Initiative
NVH: Noise Vibration and Harshness
PPP: Public Private Partnership
PPP: Purchasing Power Parity
R&D: Research and Development
TRIPS: Trade Related Aspects of Intellectual Property Rights
USD: US Dollar
WTO: World Trade Organisation
Wherever applicable, numbers have been rounded off to the nearest whole number

5555DECEMBER 2016
Year INR equivalent of one USD
2004–05 44.81
2005–06 44.14
2006–07 45.14
2007–08 40.27
2008–09 46.14
2009–10 47.42
2010–11 45.62
2011–12 46.88
2012–13 54.31
2013–14 60.28
2014-15 61.06
2015-16 65.46
2016-17 (E) 66.95
Year INR equivalent of one USD
2005 43.98
2006 45.18
2007 41.34
2008 43.62
2009 48.42
2010 45.72
2011 46.85
2012 53.46
2013 58.44
2014 61.03
2015 64.15
2016 (Expected) 67.22
Exchange rates (Fiscal Year)
EXCHANGE RATES
Exchange rates (Calendar Year)
Source: Reserve bank of India,
Average for the year

5656DECEMBER 2016
India Brand Equity Foundation (“IBEF”) engaged TechSci to prepare this presentation and the same has been prepared
by TechSci in consultation with IBEF.
All rights reserved. All copyright in this presentation and related works is solely and exclusively owned by IBEF. The
same may not be reproduced, wholly or in part in any material form (including photocopying or storing it in any medium
by electronic means and whether or not transiently or incidentally to some other use of this presentation), modified or in
any manner communicated to any third party except with the written approval of IBEF.
This presentation is for information purposes only. While due care has been taken during the compilation of this
presentation to ensure that the information is accurate to the best of TechSci and IBEF’s knowledge and belief, the
content is not to be construed in any manner whatsoever as a substitute for professional advice.
TechSci and IBEF neither recommend nor endorse any specific products or services that may have been mentioned in
this presentation and nor do they assume any liability or responsibility for the outcome of decisions taken as a result of
any reliance placed on this presentation.
Neither TechSci nor IBEF shall be liable for any direct or indirect damages that may arise due to any act or omission on
the part of the user due to any reliance placed or guidance taken from any portion of this presentation.
DISCLAIMER

Innovation and Patents Sectore Report - December 2016

Recommended

Recommended

More Related Content

What's hot

What's hot (18)

Viewers also liked

Viewers also liked (20)

Similar to Innovation and Patents Sectore Report - December 2016

Similar to Innovation and Patents Sectore Report - December 2016 (17)

More from India Brand Equity Foundation

More from India Brand Equity Foundation (20)

Recently uploaded

Recently uploaded (20)

Innovation and Patents Sectore Report - December 2016